Zevra Therapeutics OverviewZevra Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for KMPH.
Quarterly EBIT
$52.15M
↑ 1072.51% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$5.04M
↑ 96.7% YoY
Trailing 12 months ending Mar 31, 2026
Zevra Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for KMPH.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026